HRMY
Harmony Biosciences Holdings Inc
Price:  
32.39 
USD
Volume:  
386,485.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HRMY Probability of Bankruptcy

The Probability of Bankruptcy of Harmony Biosciences Holdings Inc (HRMY) is 3.88% . This number represents the probability that HRMY will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating HRMY's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

HRMY - ESG ratings

ESG ratings are directly linked to the cost of capital and HRMY's ability to raise funding, both of which can significantly affect the probability of Harmony Biosciences Holdings Inc going bankrupt.

ESG Score 36.86
Environment Score 40.61
Social Score 32.05
Governance Score 37.92
Returns
Historical Returns (5 day) -3.26%
Historical Returns (MTD) -6.58%
Historical Returns (YTD) 0.28%
Historical Returns (13 week) -16.76%
Historical Returns (26 week) 9.09%
Historical Returns (52 week) -4.11%
Efficiency
Asset Turnover 0.79
Receiveable Turnover 9.16
Gross Margin 78.65%
Operating Margin 25.71%
Pretax Margin 25.71%
Net Margin 17.98%
Return on Asset (ROA) 14.24
Return on Equity (ROE) 23.16
Return on Investments (ROI) 17.09
Price Metrics
Market Cap (M) 1,847.20
Enterprise Value (M)
52 Week High 41.61
52 Week Low 28.14
Beta 1.28
Average Volume (10 day) 0.48
Average Volume (3 month) 0.62
Price / Earnings (P/E) 15.06
Price / Sales (P/S) 2.71
Earnings
EPS 2.11
Revenue CAGR (5 year)
Risk
Current Ratio 3.24
Quick Ratio 3.10